Ophthalmology News and Research

RSS

Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.

New Merck set to begin global health care operations

Merck & Co., Inc. today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.

5 Nov 2009

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

Marking a significant bench to bedside research milestone in Singapore, the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, and the National University Hospital (NUH) launched the IBN iCare and the NUH Eye Centre @ Biopolis at an official opening ceremony officiated by the Senior Minister of State for Trade and Industry and Education, S. Iswaran, at the Biopolis on Nov. 3, 2009.

4 Nov 2009

MedInformatix demonstrates its PM and EMR Solution at 2009 AAO Conference

MedInformatix, a leading provider of software solutions for the healthcare industry, announced the tenth anniversary of its relationships with several prominent Midwestern ophthalmology practices at the 2009 American Academy of Ophthalmology (AAO) Conference in San Francisco. In each case, the practices showcase the benefits of MedInformatix's Practice Management (PM) and Electronic Medical Records (EMR) Solution.

4 Nov 2009

Multicenter study finds AMD patients can benefit from cataract surgery

This month's Ophthalmology, the journal of the American Academy of Ophthalmology (Academy) reports on a national study that finds cataract surgery is likely to benefit patients with age-related macular degeneration (AMD) at all stages of the disease, on a clinical trial showing that the steroid triamcinolone may be effective in advanced diabetic macular edema (DME) patients when standard treatment fails, and on the public's use of two Academy-sponsored online eye health forums.

2 Nov 2009

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

Like all tissues in the body, the eye needs a healthy blood supply to function properly. Poorly developed blood vessels can lead to visual impairment or even blindness. While many of the molecules involved in guiding the development of the intricate blood vessel architecture are known, only now are we learning how these molecules work and how they might affect sight.

31 Oct 2009

Annual dilated eye exam helps prevent vision loss in people with diabetes

Diabetes causes more new cases of legal blindness among working-age Americans than any other disease. If diabetics are monitored regularly by their ophthalmologist, this vision loss is almost always avoidable. Yet, tragically, more than half of all people living with diabetes do not get the recommended annual dilated eye exam.

30 Oct 2009

sanofi-aventis reports financial results for the third quarter of 2009

In the third quarter of 2009, sanofi-aventis generated net sales of euro 7,400 million, up 8.0% on a reported basis. Exchange rate movements had a favorable effect of 2.0 percentage points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies.

30 Oct 2009

UT Southwestern ophthalmologist receives 2009 Castroviejo Medal

Dr. H. Dwight Cavanagh, vice chairman of ophthalmology at UT Southwestern Medical Center, has been named the 2009 recipient of the prestigious Castroviejo Medal, one of the top ophthalmology prizes in the world.

30 Oct 2009

Researchers discover new bend in gene control

Since the completion of the human genome sequence, a question has baffled researchers studying gene control: How is it that humans, being far more complex than the lowly yeast, do not proportionally contain in our genome significantly more gene-control proteins?

30 Oct 2009

New center to provide variety of medical services for people in and around Skid Row opened

The Weingart Center Association, JWCH Institute and the County of Los Angeles announced today the opening of the Center for Community Health Downtown Los Angeles, a state-of-the-art medical facility that provides integrated care to the more than 18,000 homeless and low-income people in and around Skid Row.

30 Oct 2009

USC to develop stem cell-based treatment for age-related macular degeneration with CIRM grant

Physician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute of Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly.

29 Oct 2009

USC researchers receive grant to develop stem cell-based treatment for age-related macular degeneration

29 Oct 2009

Veterans with TBI vision loss have poor quality of life compared to civilian patients

Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor's insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucinations due to Charles Bonnet syndrome.

28 Oct 2009

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.

28 Oct 2009

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Isotechnika Pharma Inc. today announced that results of the international Phase 2/3 clinical trials studying voclosporin, conducted by its partner Lux Biosciences, were the subject of two podium presentations at the American Association of Ophthalmology (AAO) meeting and of a presentation at the satellite meeting of the American Uveitis Society (AUS) in San Francisco, October 24-27.

27 Oct 2009

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university's Department of Biomedical Engineering.

27 Oct 2009

LX211 may become the first approved oral treatment for modifying the course of uveitis

An experimental drug, LX211 (LUVENIQ-; oral voclosporin), may become the first approved oral treatment capable of modifying the course of uveitis, a group of serious eye conditions inevitably associated with either severe vision loss or substantial morbidity from steroid use.

27 Oct 2009

Some patients with AMD develop elevated pressure within the eye following anti-VEGF medications: Study

A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).

27 Oct 2009

Implantation of blue light-filtering intraocular lens increases nutritional component of the eye

Results of an important new study show that implantation of blue light-filtering intraocular lens (IOLs) at the time of cataract surgery increases a nutritional component of the eye, which may afford protection against the development and/or progression of age-related macular degeneration (AMD).

27 Oct 2009

STAAR Surgical Company reports promising assessments from CAST

STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products today reported that the Collamer Accommodating Study Team (CAST) formed by the company in late 2008 has provided very promising initial patient vision assessments from the first phase of the project.

26 Oct 2009

Ophthalmology News and Research

Further Reading

New Merck set to begin global health care operations

IBN iCare to develop cutting-edge nanomaterials for ocular therapy

MedInformatix demonstrates its PM and EMR Solution at 2009 AAO Conference

Multicenter study finds AMD patients can benefit from cataract surgery

Johns Hopkins researchers find life in blood-starved retinas; shed light on vision loss

Annual dilated eye exam helps prevent vision loss in people with diabetes

sanofi-aventis reports financial results for the third quarter of 2009

UT Southwestern ophthalmologist receives 2009 Castroviejo Medal

Researchers discover new bend in gene control

New center to provide variety of medical services for people in and around Skid Row opened

USC to develop stem cell-based treatment for age-related macular degeneration with CIRM grant

USC researchers receive grant to develop stem cell-based treatment for age-related macular degeneration

Veterans with TBI vision loss have poor quality of life compared to civilian patients

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

CWRU grants licensing agreement to Bioptigen for FDOCT technology

LX211 may become the first approved oral treatment for modifying the course of uveitis

Some patients with AMD develop elevated pressure within the eye following anti-VEGF medications: Study

Implantation of blue light-filtering intraocular lens increases nutritional component of the eye

STAAR Surgical Company reports promising assessments from CAST

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News